688253 Stock Overview
Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 6/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Innovita Biological Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥39.63 |
| 52 Week High | CN¥47.85 |
| 52 Week Low | CN¥19.12 |
| Beta | 1.14 |
| 11 Month Change | 6.10% |
| 3 Month Change | 8.04% |
| 1 Year Change | 89.62% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 34.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688253 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 11.3% | 15.0% | 15.4% |
| 1Y | 89.6% | -10.9% | -7.9% |
Return vs Industry: 688253 exceeded the CN Medical Equipment industry which returned -10.9% over the past year.
Return vs Market: 688253 exceeded the CN Market which returned -7.9% over the past year.
Price Volatility
| 688253 volatility | |
|---|---|
| 688253 Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.5% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 688253 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688253's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 453 | Xiujie Zhang | www.innovita.com.cn |
Innovita Biological Technology Co., Ltd. engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; emergency outpatient testing; coronavirus testing; respiratory infections solutions; pregnancy test; hepatitis virus testing ; and enterovirus testing . The company was founded in 2006 and is based in Beijing, China.
Innovita Biological Technology Co., Ltd. Fundamentals Summary
| 688253 fundamental statistics | |
|---|---|
| Market cap | CN¥5.39b |
| Earnings (TTM) | CN¥302.80m |
| Revenue (TTM) | CN¥675.50m |
19.7x
P/E Ratio8.8x
P/S RatioIs 688253 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688253 income statement (TTM) | |
|---|---|
| Revenue | CN¥675.50m |
| Cost of Revenue | CN¥130.84m |
| Gross Profit | CN¥544.66m |
| Other Expenses | CN¥241.86m |
| Earnings | CN¥302.80m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 26, 2024
| Earnings per share (EPS) | 2.23 |
| Gross Margin | 80.63% |
| Net Profit Margin | 44.83% |
| Debt/Equity Ratio | 0% |
How did 688253 perform over the long term?
See historical performance and comparison